Abstract
The relationship of chemicals to urinary bladder carcinogenesis was initially observed in the species of ultimate concern in cancer research -- the human being. Rehn in 1895 noticed an increased incidence of cancer of the urinary bladder in workers in the German aniline dye industry (1,2). Hueper and his colleagues were able to demonstrate that one of the carcinogens to which these workers were exposed was 2-aminonaphthalene. Hueper’s experiments involving dogs also demonstrated the necessity for relatively high doses of the carcinogen and the long periods of time required for the experimental induction of bladder cancer (1,2). Aromatic amines since then have remained of central importance in bladder cancer research in animals and in humans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Clayson, D.B., and E.H. Cooper. 1970. Cancer of the urinary tract. Adv. Cancer Res. 13: 271–381.
Price, J.M. 1971. Etiology of bladder cancer. In: Benign and Malignant Tumors of the Urinary Bladder. E. Maltry, ed. Medical Examination Publishing Co., Inc.: Flushing, NY. pp. 189–251.
Johansson, S., L. Angervall, U. Bengtsson, and L. Wahlquist. 1974. Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin-containing analgesics. Cancer 33: 743–753.
Lomax-Smith, J., and A.E. Seymour. 1980. Unsuspected analgesic nephropathy in transitional cell carcinoma of the upper tract: A morphological study. Histopathology 4: 255–269.
Miller, J.A., and E.C. Miller. 1977. Ultimate chemical carcinogens as reactive mutagenic electrophiles. In: Origins of Human Cancer, Cold Spring Harbor Conferences on Cell Proliferation, Volume 4. H.H. Hiatt, J.D. Watson, and J.A. Winsten, eds. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY. pp. 605–627.
Glowinski, I.B., H.E. Radtke, and W.W. Weber. 1978. Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver. Molec. Pharmacol. 14: 940–949.
Lower, G.M., T. Nilsson, C.E. Nelson, H. Wolfe, T.E. Gamsky, and G.T. Bryan. 1979. N-Acetyltransferase phenotype and risk in urinary bladder cancer: Approaches in molecular epidemiology. Environ. Hlth. Perspect. 29: 71–79.
Kadlubar, F.F., J.A. Miller, and E.C. Miller. 1977. Hepatic microsomal N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res. 37: 805–814.
Radomski, J.L., J.M. Poupko, and W.L. Hearn. 1980. Environmental bladder carcinogens. National Bladder Cancer Project Abstracts, Saratoga, FL. p. 35 (abstract).
Cohen, S.M., T.V. Zenser, G. Murasaki, S. Fukushima, M.B. Mattammal, N.S. Rapp, and B.B. Davis. (1981). Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamideinduced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase. Cancer Res. 41: 3355–3359.
Druckrey, H., R. Preussmann, D. Schmähl, and S. Ivankovic. 1967. Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten. Z. Krebsforsch. 69: 103–201.
Cohen, S.M. 1978. Toxicity and carcinogenicity of nitrofurans. In: Carcinogenesis–A Comprehensive Survey, Volume 4, Nitrofurans. G.T. Bryan, ed. Raven Press: New York. pp. 171–231.
Hicks, R.M., and J.St.J. Wakefield. 1972. Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea. I. Histology. Chem.-Biol. Interact. 5: 139–152.
Erturk, E., S.M. Cohen, J.M. Price, and G.T. Bryan. 1969. Pathogenesis, histogenesis, histology, and transplantability of urinary bladder carcinoma induced in albino rats by oral administration of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Res. 29: 2219–2228.
Wang, C.Y., and Y. Kamirya. 1978. Carcinogenicity of 2-amino-4-(5-nitro-2-furyl)thiazole in rats and metabolism of this carcinogen by cultured dog urothelial cells. Proc. Am. Assoc. Cancer Res. 19: 146 (abstract).
Swaminathan, S., and G.M. Lower, Jr. 1978. Biotransformations and excretion of nitrofurans. In: Carcinogenesis–A Comprehensive Survey, Volume 4, Nitrofurans. G.T. Bryan, ed. Raven Press: New York. pp. 59–97.
Wang, C.Y., R.C. Benson, Jr., and G.T. Bryan. 1977. Mutagenicity for Salmonella typhimurium of urine obtained from humans receiving nitrofurantoin. J. Natl. Cancer Inst. 58: 871–873.
Tiltman, A.J., and G.H. Friedell. 1971. The histogenesis of experimental bladder cancer. Invest. Urol. 9: 218–226.
Cohen, S.M., J.B. Jacobs, M. Arai, S. Johansson, and G.H. Friedell. 1976. Early lesions in experimental bladder cancer: Experimental design and light microscopic findings. Cancer Res. 36: 2508–2511.
Arai, M., S.M. Cohen, J.B. Jacobs, and G.H. Friedell. 1979. Effect of dose on urinary bladder carcinogenesis induced in F344 rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. J. Natl. Cancer Inst. 62: 1013–1016.
Jacobs, J.B., M. Arai, S.M. Cohen, and G.H. Friedell. 1977. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)2-thiazolyl]formamide. Cancer Res. 37: 2817–2821.
Cohen, S.M., M. Arai, J.B. Jacobs, and G.H. Friedell. 1979. Promoting effect of saccharin and D,L-tryptophan in urinary bladder carcinogenesis. Cancer Res. 39: 1207–1217.
Tsuda, H., Y. Miyata, G. Murasaki, H. Kinoshita, S. Fukushima, and N. Ito. 1977. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide, N-2-fluorenylacetamide, and 3,3’-dichlorobenzidine. Gann 68: 183–192.
Tatematsu, M., Y. Miyata, M. Mizutani, M. Hananouchi, M. Hirose, and N. Ito. 1977. Summation effect of N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide, N-2-fluorenylacetamide, and 3,3’-dichlorobenzidine on urinary bladder carcinogenesis in rats. Gann 68: 193–202.
Hicks, R.M., J.St.J. Wakefield, and J. Chowaniec. 1975. Evaluation of a new model to detect bladder carcinogens or cocarcinogens; results obtained with saccharin, cyclamate and cyclophosphamide. Chem.-Biol. Interact. 11: 225–233.
Nakanishi, K., M. Hirose, T. Ogiso, R. Hasegawa, M. Arai, and N. Ito. 1980. Effects of sodium saccharin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 71: 490–500.
Nakanishi, K., S. Fukushima, M. Shibata, T. Shirai, T. Ogiso, and N. Ito. 1978. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 69:395–400.
Friedell, G.H., S.M. Cohen, D.M. Demers, S. Fukushima, and J.B. Jacobs. 1980. Promoting effects of sodium saccharin (NaS) and L-tryptophan (L-T) in rat urinary bladder carcinogenesis and their effects on urinary constituents. Proc. Am. Assoc. Cancer Res. 21: 111 (abstract).
Radomski, J.L., T. Radomski, and W.E. MacDonald. 1977. Cocarcinogenic interaction between D,L-tryptophan and 4-aminobiphenyl or 2-naphthylamine in dogs. J. Natl. Cancer Inst. 58: 1831–1834.
Matsushima, M. 1977. The role of the promoter L-tryptophan on tumorigenesis in the urinary bladder. 2. Urinary bladder carcinogenicity of FANFT (initiating factor) and L-tryptophan (promoting factor) in mice. Jap. J. Urol. 68: 731–736.
Scribner, J.D., and R. Suss. 1978. Tumor initiation and promotion. Int. Rev. Exp. Path. 18: 137–198.
Cancer Testing Technology and Saccharin. 1977. Office of Technology Assessment. United States Government Printing Office: Washington, DC.
Bowden, J.P., K.T. Chung, and A.W. Andrews. 1976. Mutagenic activity of tryptophan metabolites produced by rat intestinal microflora. J. Natl. Cancer Inst. 57: 921–924.
Fukushima, S., and S.M. Cohen. 1980. Saccharin-induced hyperplasia of the rat urinary bladder. Cancer Res. 40: 734–736.
Murasaki, G., and S.M. Cohen. (1981). Effect of dose of sodium saccharin on the induction of rat urinary bladder proliferation. Cancer Res. 41: 942–944.
Radomski, J.L., E.M. Glass, and W.B. Deichmann. 1971. Transitional cell hyperplasia in the bladders of dogs fed D,L-tryptophan. Cancer Res. 31: 1690–1694.
Scott, W.W., and H.L. Boyd. 1953. A study of the carcinogenic effect of beta-naphthylamine on the normal and substituted isolated sigmoid loop bladder of dogs. J. Urol. 70: 914–925.
McDonald, D.F., and R.R. Lund. 1954. The role of the urine in vesical neoplasm. 1. Experimental confirmation of the urogenous theory of pathogenesis. J. Urol. 71: 560–570.
Chapman, W.H., D. Kirchheim, and J.W. McRoberts. 1973. Effect of the urine and calculus formation on the incidence of bladder tumors in rats implanted with paraffin wax pellets. Cancer Res. 33: 1225–1229.
Bryan, G.T., and P.D. Springberg. 1966. Role of the vehicle in the genesis of bladder carcinomas in mice by the pellet implantation technique. Cancer Res. 26: 105–109.
Rowland, R.G., M.O. Henneberry, R. Oyasu, and J.T. Grayback. 1980. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions. Cancer Res. 40: 4524–4527.
Oyasu, R., Y. Hirao, and K. Izumi. 1981. Enhancement by urine of urinary bladder carcinogenesis. Cancer Res. 41: 478–481.
Izumi, K., Y. Hirao, L. Hopp, and R. Oyasu. 1981. In vitro induction of ornithine decarboxylase in urinary bladder carcinoma cells. Cancer Res. 41: 405–409.
Boutwell, R.K. 1964. Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res. 4: 207–250.
Slaga, T.J., S.M. Fischer, K. Nelson, and G.L. Gleason. 1980. Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion. Proc. Natl. Acad. Sci. USA 77: 3659–3663.
Minsky, B.D., and F.J. Chlapowski. 1978. Morphometric analysis of the translocation of lumenal membrane between cytoplasm and cell surface of transitional epithelial cells during the expansion-contraction cycles of mammalian urinary bladder. J. Cell Biol. 77: 685–697.
Murasaki, G., S. Fukushima, R.E. Greenfield, and S.M. Cohen. (1981). Effect of ulceration on urinary bladder carcinogenesis induced by N-[4-(5-nitro-2-furyl)2-thiazolyl]formamide (FANFT) and sodium saccharin (SAC). Proc. Am. Assoc. Cancer Res. (abstract) 22: 128.
Shirai, T., S.M. Cohen, S. Fukushima, M. Hananouchi, and N. Ito. 1978. Reversible papillary hyperplasia of the rat urinary bladder. Am. J. Path. 91: 33–48.
Arnold, D.L., C.A. Moodie, H.C. Grice, S.M. Charbonneau, B. Stavric, B.T. Collins, P.F. McGuire, Z.Z. Zawidska, and I.C. Munro. 1980. Long-term toxicity of ortho-toluenesulfonamide and sodium saccharin in the rat. Toxicol. Appl. Pharmacol. 52: 113–152.
Bryan, G.T., E. Erturk, and O. Yoshida. 1970. Production of urinary bladder carcinomas in mice by sodium saccharin. Science 168: 1238–1240.
Fukushima, S., S.M. Cohen, M. Arai, J.B. Jacobs, and G.H. Friedell. (1981). Scanning electron microscopy of reversible hyperplasia of the rat urinary bladder. Am. J. Path. 102: 373–380.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Cohen, S.M. (1983). Promotion of Urinary Bladder Carcinogenesis. In: Langenbach, R., Nesnow, S., Rice, J.M. (eds) Organ and Species Specificity in Chemical Carcinogenesis. Basic Life Sciences. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4400-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4400-1_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4402-5
Online ISBN: 978-1-4684-4400-1
eBook Packages: Springer Book Archive